5227 indexable HealthTech companies headquartered in California, United States, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $70.8B across 1921 funded companies, including 44 unicorns.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
Cala Health
Developer of a wearable non-invasive neuromodulation device |
$157.1M | — | Series D | Conventional Debt Apr 2026 | 50 | 2013 | ↑ Active |
| 2 |
Iambic Therapeutics
Provider of AI-driven drug discovery platform for the treatment of cancer |
$206.2M | — | Series C | Series C Apr 2026 | 50 | 2019 | ↑ Active |
| 3 |
Qualified Health
Provider of an enterprise AI platform for healthcare systems |
$155M | — | Series B | Series B Mar 2026 | — | 2023 | ↑ Active |
| 4 |
BigHealth
CBT therapy for insomnia patients |
$129.3M | — | Series C | Series C Feb 2026 | 251 | 2010 | ↑ Active |
| 5 |
BrightInsight
Provider of digital health solutions for clinical trials |
$166.1M | — | Series C | Series C Jan 2026 | 165 | 2017 | ↑ Active |
| 6 |
Cartography Biosciences
Provider of a platform to discover immunotherapeutics |
$57M | — | Series B | Series B May 2026 | 10 | 2020 | ↑ Active |
| 7 |
Signos
Provider of a wearable device for blood glucose pattern monitoring |
$37M | — | Series B | Series B May 2026 | 30 | 2020 | ↑ Active |
| 8 |
Fathom
Provider of autonomous medical coding platform and related coding services |
$61M | — | Series B | Series B May 2026 | 79 | 2017 | ↑ Active |
| 9 |
Join Midi
Unicorn Provider of a virtual care platform focused on female midlife health |
$104M | — | Series D | Series D Feb 2026 | 52 | 2021 | ↑ Active |
| 10 |
Aureka Biotechnologies
Biotech company digitizing therapeutic discovery to manage human health |
$58M | — | Series A | Series A Apr 2026 | — | 2023 | ↑ Active |
| 11 |
Chai Discovery
Unicorn Developer of artificial intelligence models for de novo molecular design |
$230M | — | Series B | Series B Dec 2025 | — | 2023 | ↑ Active |
| 12 |
Triomics
Provider of clinical research and clinical trial tracking software |
$28.9M | — | Series B | Series B May 2026 | 29 | 2020 | ↑ Active |
| 13 |
Quartzy
Provider of web-based platform for labs management |
$33.9M | — | Series C | Series C Apr 2026 | 97 | 2009 | ↑ Active |
| 14 |
Turquoise
Online platform for employee health benefits |
$55M | — | Series C | Series C Mar 2026 | 52 | 2020 | ↑ Active |
| 15 |
Hippocratic AI
Unicorn Developer of safety-focused generative AI for healthcare |
$137M | $500M as of 2024 |
Series C | Series C Nov 2025 | 35 | 2022 | ↑ Active |
| 16 |
HeartFlow
Unicorn Provides cardiovascular diagnostic support using analytics |
$837.7M | $1.3B as of 2019 |
Public | Series F Mar 2025 | 363 | 2007 | ↑ Active |
| 17 |
Unnatural Products
Developer of computational biology techniques platform to engineer peptides for undruggable targets |
$38M | — | Series B | Series B Mar 2026 | 22 | 2016 | ↑ Active |
| 18 |
Digital Optics Corporation
Unicorn Provides MEMS technology based camera lens and modules |
$45M | $1.3B as of 2024 |
Acquired | Series B Feb 2026 | 23 | 1990 | ↑ Active |
| 19 |
Luminai
Artificial intelligence based platform offering internal workflow automation solutions |
$24.1M | — | Series B | Series B Apr 2026 | 9 | 2019 | ↑ Active |
| 20 |
Visby Medical
Unicorn Provider of at-home tests for sexually transmitted infections with telehealth |
$331.3M | $1B as of 2022 |
Series F | Series F Jun 2025 | 251 | 2010 | ↑ Active |
| 21 |
Enlitic
AI-based radiology database management tool |
$55M | — | Public | Post IPO Dec 2025 | 16 | 2014 | ↑ Active |
| 22 |
Sinopia Biosciences
Data-driven drug discovery using multi-omics, AI, and disease models |
$19.4M | — | Funding Raised | Grant (prize money) Mar 2026 | 4 | 2014 | ↑ Active |
| 23 |
9amHealth
Provider of whole-body approach to healthcare delivering multiple services |
$29.8M | — | Series B | Series B Mar 2026 | 35 | 2021 | ↑ Active |
| 24 |
Exo
Developer of point of care ultrasound ecosystem with AI-powered diagnostic and workflow tools |
$346M | — | Series C | Series C May 2025 | 152 | 2015 | ↑ Active |
| 25 |
Tebra
Unicorn Cloud based platform offering practice management tool for providers |
$72M | $1B as of 2022 |
Series D | Series D Dec 2025 | 1,000 | 2021 | ↑ Active |
| 26 |
General Proximity
Developer of next generation of induced-proximity medicines |
$16M | — | Seed | Seed May 2026 | 11 | 2023 | ↑ Active |
| 27 |
Condor
Software-based financial management platform for clinical industries |
$24M | — | Series A | Series A Mar 2026 | 8 | 2003 | ↑ Active |
| 28 |
Cognixion
Developer of an AI and AR-based application for speech impaired individuals |
$23.1M | — | Series A | Conventional Debt Jan 2026 | 34 | 2014 | ↑ Active |
| 29 |
Eikon
Unicorn Protein tracking and measuring tool for drug discovery |
$668M | $3.1B as of 2023 |
Public | Series D Feb 2025 | 331 | 2019 | ↑ Active |
| 30 |
Aumet
Provider of B2B transaction management solutions for healthcare companies |
$8.2M | — | Series A | Series A May 2026 | 133 | 2016 | ↑ Active |
| 31 |
Neuron23
AI-based drug discovery model for researchers |
$213.5M | — | Series D | Series D Jun 2025 | 29 | 2018 | ↑ Active |
| 32 |
Modern Animal
Platform offering virtual veterinary care services |
$89M | — | Acquired | Series D Sep 2025 | 163 | 2018 | ↑ Active |
| 33 |
PreludeDx
Provider of risk assessment test for early stage breast cancer |
$46.7M | — | Series B | Series B Oct 2025 | 33 | 2009 | ↑ Active |
| 34 |
Twin Health
Provider of personalized metabolic health programs |
$271.9M | — | Series E | Series E May 2025 | 209 | 2018 | ↑ Active |
| 35 |
Century Health
AI-powered health tech company accelerating access to breakthrough treatments |
$7M | — | Seed | Seed May 2026 | — | 2023 | ↑ Active |
| 36 |
Blank Bio
Developer of RNA foundation models for precision medicine research applications |
$7.2M | — | Seed | Seed May 2026 | — | 2025 | ↑ Active |
| 37 |
Equip
Provider of virtual therapy and consultation for eating disorders |
$130M | — | Series C | Series C Jul 2025 | 32 | 2019 | ↑ Active |
| 38 |
Strava
Unicorn Provider of application for tracking, analyzing, and sharing fitness activities |
$180M | $1.5B as of 2020 |
Series G | Conventional Debt Jun 2025 | 290 | 2009 | ↑ Active |
| 39 |
NewLimit
Unicorn Developer of epigenetic reprogramming medicines for aging-related diseases and healthspan extension |
$60M | — | Series B | Series B Oct 2025 | 8 | 2022 | ↑ Active |
| 40 |
BridGene Biosciences
Developer of small-molecule drugs for the treatment of cancer |
$50.5M | — | Series B | Series B Oct 2025 | 25 | 2018 | ↑ Active |
| 41 |
Profluent Bio
Provider of an artificial intelligence-based protein design platform |
$44M | — | Series B | Series B Nov 2025 | 10 | 2022 | ↑ Active |
| 42 |
Earlens Corporation
Provider of hearing aids for people with less hearing power |
$326.3M | — | Series E | Series E Feb 2025 | 129 | 2005 | ↑ Active |
| 43 |
Hims
Online platform offering telehealth services for men's wellness |
$197M | — | Public | Post IPO May 2025 | 1,046 | 2017 | ↑ Active |
| 44 |
Evidation
Real-world health data insights for better healthcare decisions and research |
$259.2M | — | Series E | Grant (prize money) Mar 2025 | 196 | 2012 | ↑ Active |
| 45 |
Medallion
Cloud-based solution for licensing, credentialing, and other practice management for healthcare providers |
$85M | — | Series D | Series D Aug 2025 | 172 | 2011 | ↑ Active |
| 46 |
Phil
Technology-driven hub simplifying medication access and improving patient outcomes |
$98M | — | Series D | Venture Debt Jul 2025 | 99 | 2015 | ↑ Active |
| 47 |
Innovaccer
Unicorn Developer of healthcare data platforms and artificial intelligence agent software |
$378.6M | $3.2B as of 2021 |
Series F | Series F Jan 2025 | 1,003 | 2014 | ↑ Active |
| 48 |
House Rx
Provider of a technology-based medication solution for patients and caregivers |
$34M | — | Series B | Series B Nov 2025 | 94 | 2005 | ↑ Active |
| 49 |
Boost
Developer of software for managing behavioral health practice administrative workflows |
$10.9M | — | Series B | Series B Mar 2026 | — | 2019 | ↑ Active |
| 50 |
Solace Health
Unicorn Provider of patient centered healthcare platform |
$14M | — | Series C | Series C Feb 2026 | 1 | 2022 | ↑ Active |
Developer of a wearable non-invasive neuromodulation device. The company has developed a neuromodulation device that aims to provide relief of hand tremors in adults with essential tremors. It combines a watch-like device with an implantable sensor that externally stimulates peripheral nerves to reduce the same. The company has also developed a portable medical device with sensors to monitor the physical movement of
Provider of AI-driven drug discovery platform for the treatment of cancer. It offers an AI driven discovery platform and has discovered two candidates known as IAM-H1, a highly selective and brain penetrant inhibitor of HER2 and its oncogenic mutants, and IAM-C1 a potential first-in-class selective dual CDK2/4 inhibitor to address unmet needs in terms of therapeutic window and treatment resistance in cell cycle drive
Provider of an enterprise AI platform for healthcare systems. The platform unifies workflows, use cases, and models under a governed operating layer. It offers data integration, deployable solutions, and workflow builder tools. The platform provides governance, workforce education, and continuous outcome tracking.
CBT therapy for insomnia patients. Its flagship product Sleepio is a digital sleep improvement program, clinically proven to help users overcome poor sleep. Its virtual sleep expert "The Prof" teaches users proven Cognitive Behavioral Therapy (CBT) techniques, personalized to their problems and monitors their progress. Sleepio has been validated in the world’s first placebo-controlled RCT for a digital sleep interv
BrightInsight provides digital health solutions for clinical trials. Their platform enables improving patient engagement and adherence, continuous remote patient monitoring, and dose management algorithms (cloud-based algorithm). It analyzes data from connected medical devices, combination products, apps, and software. The company's Quality Management System is ISO 13485: 2016 certified.
Provider of a platform to discover immunotherapeutics. It provides a platform that combines computational and experimental techniques to profile antigens of cancerous cells and identify targets for immuno-oncology treatments.
Provider of a wearable device for blood glucose pattern monitoring. The company has developed an app-based platform that recommends meals and exercises for users based on the glucose pattern detected through the connected device. The app provides real-time glucose monitoring and glucose spike levels for different foods. Based on this, personalized fitness and nutrition plan can be developed.
Provider of autonomous medical coding platform and related coding services. The company offers production coding, backlog processing, and real-time audit functionalities. The platform automates medical coding, aiming to reduce costs and improve accuracy. It provides coding capacity and helps to review coding work.
Provider of a virtual care platform focused on female midlife health
Biotech company digitizing therapeutic discovery to manage human health. It utilize microfluidics in use of drug discovery and offer solutions for pharmaceutical and biotech research using artificial intelligence. The platform offers immunotherapeutic discovery, developing new therapeutics, drug discovery, single-cell-based functional screening and AI-based drug design and development for generating multi metric data
Developer of artificial intelligence models for de novo molecular design. The company focuses on engineering better molecules through advanced computational methods. It introduces new model series designed to achieve high hit rates in antibody design. The company provides access to its technology for molecular research and development.
Provider of clinical research and clinical trial tracking software. The features of the software include an end-to-end platform for running clinical trials, unifying the workflows of clinical care and clinical research, and eliminating the operational inefficiencies in data collection, patient recruitment, and other laborious tasks involved in clinical research.
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-16.